What Biobase does

Biobase is a privately held healthcare data infrastructure company headquartered in San Diego, California, incorporated in Delaware and founded in 2025. The company provides a federated operating system for multimodal clinical data that connects healthcare data suppliers (labs, hospitals, and health systems) with research buyers (pharma, biotech, AI companies, and CROs). Its platform enables compliant, privacy-preserving data exchange without raw data movement and consists of seven integrated modules: the core Agentic Operating System, Natural Language Querying, Federated Architecture, Built-In HIPAA Compliance, Multi-Modal Integration (pathology, molecular, genomic, and outcomes), Agentic Workflows for automated procurement, and Clinical Trial Matching.

The technology stack centers on an AI-native agentic architecture where AI agents automate cohort building, analytics, workflow orchestration, and procurement—compressing procurement cycles from months to minutes per company claims. The platform supports natural language querying across multimodal datasets, federated compute for privacy preservation, and built-in de-identification and consent management. Biobase serves two primary vertical segments: Healthcare and Lab Partners seeking to monetize clinical data assets, and Life Sciences and Biotech buyers seeking instant access to multimodal datasets for drug discovery, clinical trials, and AI development.

Biobase generates revenue through multiple streams including marketplace commissions on data transactions, transaction fees for data asset commercialization services, and subscription-based AI-powered internal tools for healthcare institutions. The go-to-market combines enterprise field sales (Request a Demo CTAs targeting healthcare systems and life sciences buyers) with product-led growth through self-serve natural language exploration. Pricing is quote-based and not publicly disclosed. The team of approximately six includes five co-founders with prior experience at Paige, Pictor Labs, Danaher, OTTO, Grasshopper, Augmedix, Arterys, Elephas, Walgreens, PwC, IBEX, Olympus, and Philips Healthcare, plus a Head of AI and a Data Engineering lead.

Name

Biobase

Legal name

Biobase, Inc.

Website

https://biobase.ai

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

11–50 employees

Short description

Biobase is a healthcare data infrastructure company providing a federated, AI-native operating system for multimodal clinical data, connecting healthcare providers and life sciences organizations through privacy-preserving compute and agentic workflow automation.

Ownership category

akta.pro rank

Product category

Healthcare Data Infrastructure

NAICS

Software Publishers (5132)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

akta.pro secondary industries

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Clinical data infrastructure
• Federated data platform
• Healthcare data monetization
• Agentic AI workflows
• Multimodal data integration

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Data Monetization Platform Fees: Platform facilitates connections between healthcare data suppliers and life sciences buyers, earning fees for enabling compliant data transactions.
2. Data Asset Commercialization Services: Helps labs, hospitals, and health systems monetize clinical data assets (pathology, molecular, outcomes) into revenue streams while handling compliance and de-identification.
3. AI-Powered Internal Tools: Natural language querying and analytics tools for internal workflows at healthcare institutions.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Biobase provides "The Agentic Operating System for Clinical Data," a federated software platform that enables compliant, privacy-preserving connections between healthcare data suppliers (labs, hospitals, health systems) and life sciences buyers (pharma, biotech, AI companies, CROs). The platform unifies multimodal clinical data (pathology, molecular, genomic, outcomes), automates cohort building, dataset discovery, feasibility analysis, clinical trial matching, and contracting through AI agents, and embeds HIPAA-grade compliance, consent management, and de-identification as core infrastructure. It delivers internal natural-language-query analytics tools to healthcare institutions and a compliant data-commercialization channel on the buyer side.

Product overview

Biobase offers a unified Health Data Operating System called 'The Agentic Operating System for Clinical Data'—a federated platform for multimodal clinical data that enables compliant, privacy-preserving connections between healthcare systems and research buyers. The platform consists of seven integrated modules: the core Agentic Operating System paired with Natural Language Querying for text-based data exploration, Federated Architecture for privacy-preserving data access without raw data movement, Built-In Compliance for HIPAA and regulatory requirements, Multi-Modal Integration for pathology/molecular/genomics/outcomes data unification, Agentic Workflows for automated procurement and contracting, and Clinical Trial Matching for patient-site optimization. This architecture provides healthcare and life science organizations with an end-to-end solution for clinical data monetization, discovery, and AI-powered analytics.

Differentiator

Problem solved

Functional benefit

Products and services

• The Agentic Operating System for Clinical Data Biobase's flagship platform that serves as a federated operating system for multimodal clinical data. It enables compliant, privacy-preserving connections between healthcare systems and research buyers, providing the infrastructure layer for clinical data liquidity that powers precision medicine. Delivered to healthcare and lab partners (data suppliers) and life sciences buyers (pharma, biotech, AI companies, CROs).

Quantifiable outcome

• Procurement cycles compressed from months to minutes
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature6 records

Scale indicators1 record

Recent moves5 records

Expansion highlights6 records

Direct peers

• HealthVerity: HealthVerity provides a privacy-protected data exchange for clinical and consumer health data used by life sciences and government clients. It competes directly with Biobase in enabling compliant data transactions.
• Truveta: Truveta is a health-system-owned data platform pooling EHR records for research and life sciences use. Like Biobase, it positions itself as a regulated, consent-aware channel between providers and biopharma buyers.
• Datavant: Datavant operates a health data connectivity and de-identification platform that links patient-level data across providers and life sciences buyers. It is the most direct competitor to Biobase's data liquidity and marketplace model.
• Tempus AI: Tempus builds a multi-modal clinical data platform combining molecular, pathology, and outcomes data to serve both providers and biopharma. Its data licensing and AI-ready dataset offerings directly overlap with Biobase's supplier and buyer use cases.
• Flatiron Health: Flatiron aggregates oncology real-world data from academic and community health systems and licenses it to life sciences clients. Its data sourcing from EHRs and clinical workflows is structurally similar to Biobase's hospital data commercialization model.

Emerging players

• Seqster: Seqster offers a patient-centric interoperability platform that consolidates EHR, genomic, and wearables data. Its multi-modal integration and consent-driven sharing approach overlaps with Biobase's federated, consent-aware architecture.
• Atropos Health: Atropos Health runs real-world evidence queries on top of federated clinical data for providers and life sciences customers. It competes with Biobase in serving biopharma with rapid, compliant access to clinical datasets.

Broad incumbents

• AWS HealthLake: AWS HealthLake is a managed cloud service for storing, querying, and analyzing clinical data at scale. It competes with Biobase as a horizontal infrastructure layer that health systems could use for similar data liquidity workflows.
• Verily (Alphabet): Verily operates broad real-world data and clinical evidence platforms as part of Alphabet's health portfolio. It overlaps with Biobase in delivering longitudinal, multi-modal clinical datasets to life sciences and research customers.
• Palantir Foundry: Palantir's Foundry platform is widely used by large health systems and life sciences companies to integrate and analyze multimodal clinical and operational data. It is an incumbent infrastructure option that overlaps with Biobase's positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/biobase-ai

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biobase